about
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleusAlzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficitsAlpha-synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CaMKIIPicomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy.Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficitsRegulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease.Synaptic therapy in Alzheimer's disease: a CREB-centric approach.Dynamin 1 is required for memory formationPreparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices.Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus.Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease.Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors.Beta and gamma range EEG power-spectrum correlation with spiking discharges in DBA/2J mice absence model: role of GABA receptors.Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer's disease.LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory.Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.GABAB receptor activation exacerbates spontaneous spike-and-wave discharges in DBA/2J mice.Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats.Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex.Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease.Prenatal exposure to a cannabinoid receptor agonist does not affect sensorimotor gating in rats.Incorporation and metabolism of c9,t11 and t10,c12 conjugated linoleic acid (CLA) isomers in rat brain.Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice.Effects of topiramate on the prepulse inhibition of the acoustic startle in rats.Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats.Synaptic fatigue is more pronounced in the APP/PS1 transgenic mouse model of Alzheimer's disease.Gamma-hydroxybutyric acid intake in ethanol-preferring sP and -nonpreferring sNP rats.Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid CascadeLevetiracetam attenuates spontaneous spike-and-wave discharges in DBA/2J miceSynaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade
P50
Q24806184-7B0CA0D0-381E-41DD-924E-07A232A77544Q28544876-8EDEE5B8-7FEF-4545-BC6C-4E25B341D8FFQ28591581-54327A08-EEA7-49BC-B3D9-C423914A7F5FQ28592777-F525A5F4-CC5F-46E9-B98F-BFD9E69C85FFQ34332249-FD12DC7A-C233-415C-8A3A-B46AD329EC1CQ34376044-1D4F1194-A46F-4C5F-9E60-818EDF46F7D1Q34606349-AF7299D8-4C80-4062-B15B-59B1F2BA53F1Q35064948-CA4E2857-4368-4220-B030-2E02EE8795D9Q35124338-8D5136C8-6093-4F1D-9CCF-4A633863DA09Q35164343-1E444284-1994-40C9-BD30-8FBAD8A7BF3AQ35983214-341D3C83-CF7B-4C12-9287-078B7DD2AB50Q36124990-35399C91-641A-4205-87E1-5F08D4F8AF5FQ36740290-FD710E0E-315E-47B5-B2E7-8A93BFBB3344Q38409713-30325638-BF48-48EB-87E9-131935FA46CDQ39748232-468D1B37-BD88-4072-B911-5211B4D4A7C7Q40410650-5DD14333-9F42-497E-8B04-BF58FA9DD724Q40991050-552E4AC9-5905-4D51-AAEC-4B34082B319DQ41138294-17CDA1A9-E358-4D14-B81A-CF4262936072Q41210086-0DDB35DE-91EC-40A1-B307-7F4093076950Q42693894-7B8588B7-257C-4C7C-B813-AE57FDE53333Q43127408-26076DA1-800E-4056-937D-39B0138890A4Q44296068-132E527C-B968-4F73-8FE5-9171D0835BBFQ44349387-A4F615D1-5514-4DE5-97D3-63627CBE2665Q45029887-4DC3310B-C6B0-4847-BF63-CB6FA353F3AAQ45233014-B48CACFE-A41F-443D-A018-2C9F2942A0D9Q45922651-C3AABC29-6599-486E-8E9F-1482581BA5CCQ46091355-A2B501CF-85B5-4AA9-A1F6-41D71F3EFB57Q46627835-8144C5CF-0BB3-4D48-B403-847256E691B2Q48119323-192A655A-CEA0-4341-8EF1-25B782834E88Q48489390-F8DFEE4A-108C-41A0-9C2D-E9525304019DQ48824675-1EC73EBB-D499-4FA8-845E-BB94BEAA405FQ48839054-C6799787-8CF0-4B4C-BAA2-7650B5233D57Q51511008-A7779D48-9894-4B19-BFA7-EA0CEBBF7F31Q58202799-374E79A5-D40A-4916-A2E7-8878030AC9BAQ80597801-BABC404E-2A9F-4812-B4E3-BB7AB11B43E4Q93083881-60FEB8DB-2EEF-4A6C-93F2-E9F9BD58FEFE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mauro Fà
@ast
Mauro Fà
@en
Mauro Fà
@es
Mauro Fà
@nl
Mauro Fà
@sl
type
label
Mauro Fà
@ast
Mauro Fà
@en
Mauro Fà
@es
Mauro Fà
@nl
Mauro Fà
@sl
altLabel
Mauro Fa
@en
Mauro Fa'
@en
prefLabel
Mauro Fà
@ast
Mauro Fà
@en
Mauro Fà
@es
Mauro Fà
@nl
Mauro Fà
@sl
P1053
F-5515-2011
P106
P1153
6701846988
P21
P31
P3829
P496
0000-0002-8348-0382